Stock Analysis

Trellus Health First Half 2024 Earnings: US$0.024 loss per share (vs US$0.022 loss in 1H 2023)

AIM:TRLS
Source: Shutterstock

Trellus Health (LON:TRLS) First Half 2024 Results

Key Financial Results

  • Net loss: US$3.89m (loss widened by 9.1% from 1H 2023).
  • US$0.024 loss per share (further deteriorated from US$0.022 loss in 1H 2023).
earnings-and-revenue-history
AIM:TRLS Earnings and Revenue History September 28th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Trellus Health shares are down 15% from a week ago.

Risk Analysis

Be aware that Trellus Health is showing 5 warning signs in our investment analysis that you should know about...

Valuation is complex, but we're here to simplify it.

Discover if Trellus Health might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.